Hepatitis C virus infection Infections and Infestations
Conditions
Interventions
Participants will be randomized using an online random number generator to each of the two study arms after receiving HCV education and information. The peer outreach workers will receive a weekly all
we are using this test to measure its impact on engagement in care.
Data will be collected via chart review from participant’s medical records at each of the program’s partner sites u
Sponsors
South Riverdale Community Health Centre
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 18 years or older 2. Lifetime history of injection drug use
Exclusion criteria
Exclusion criteria: 1. Currently on HCV treatment 2. Have a Sustained Virological Response (SVR) from HCV treatment in the past 3. Have had HCV testing in the past 6 months Inclusion/exclusion criteria will be by self-report.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of clients seen by the outreach workers who had a HCV RNA test completed by the TCHCP treatment nurse compared with the control group. Primary Outcomes will be measured 6 months after the data collection stage, between May and July 2019; this outcome will be measured by calculating the number of study participants who complete a HCV test with a program nurse within 6 months from the start of study enrollment, which we anticipate will take 3 months to complete. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Proportion of: participants who are newly diagnosed 2. Proportion of participants who meet other evaluation goals (phlebotomy, fibrosis assessment, ultrasound) 3. Rate of treatment initiation within 6 months of assessment All secondary outcomes will be measured in the 6 months following the participant's enrollment into the study. | — |
Countries
Canada
Contacts
Public ContactAyesha Basit
Outcome results
None listed